The purpose of this conference is to educate, promote, and support the application and use of Gallium-68 labelled agents in the diagnosis and management of oncologic diseases and the use of theranostic agents for the treatment of these diseases. The conference will feature invited and contributed talks and overviews on Ge-68/Ga-68 generators, post-processing methods, new ligands and targeting vectors, translational research on innovative theranostics, dosimetric aspects and interesting and exciting clinical results and upcoming clinical studies. Consequently, we anticipate a diverse group of participants and speakers representing the entire range of translational and clinical theranostics.
We invite you to consider providing programmatic support for the 3TWC. A limited number of exhibit spaces are available on a first-come, first-serve basis.
If you are able to support this conference in any capacity, or have any questions, please contact us.
You can download the sponsorship / exhibit forms by clicking here.
Pictures from the 1st Theranostics World Congress Exhibit Area.